0.00Open0.20Pre Close0 Volume74 Open Interest110.00Strike Price0.00Turnover7770.55%IV16.17%PremiumApr 11, 2025Expiry Date0.00Intrinsic Value100Multiplier-5DDays to Expiry0.20Extrinsic Value100Contract SizeAmericanOptions Type-0.0438Delta0.0086Gamma654.90Leverage Ratio-1086.3607Theta0.0000Rho-28.67Eff Leverage0.0001Vega
Abbott Laboratories Stock Discussion
The revenues are forecasted to come in at $10.42 billion, which would be an increase of 4.5% compared to the same period one year ago.
The consensus estimate for the earnings per share is expected to come in at an increase of 9.2% compared to same period last year, $1.07 per share.
Abbott Labs (ABT) Last Po...
Abbott's Revolutionary Sound Wave Technology Takes On America's Deadliest Disease
Cadrenal Secures FDA Orphan Drug Status and Abbott Partnership for Breakthrough Phase 3 Trial
Why invest to APLD
1. NVIDIA invests $160 million in APLD
2. Macquarie invests $5 billion in APLD
3. BlackRock purchases 15.41 million shares (disclosed in February)
4. Amazon invests $100 billion in AI and data centers
5. APLD Ellendale plant is in the final stages of completion.
1. $Super Micro Computer (SMCI.US)$'s shares jumped 17% on Monday, with the most traded calls are contracts of $50 strike price that expire on Feb 14 and the total volume reaching 68,786 with the open interest of 8,658.
The company is expected to release a business update on Tuesday. Wedbush analysts told clients in a note Monday that they believe Supermicro could successfully restate ...
I just found out Abbott is doing brain tech similar to Neuralink! They’re using deep brain stimulation to treat things like Parkinson’s and depression. It’s not as futuristic as Neuralink’s BCI, but it’s real and already helping people. Makes me wonder if they’ll dive deeper into the BCI space—it’s definitely something investors might keep an eye on! To know more about BCI, check out this video - YouTube
No comment yet